Compare Alliant Energy Corporation (LNT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Alliant Energy Corporation trades at $65.85 (market cap $16.99B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Alliant Energy Corporation is the larger of the two by market cap, and Alliant Energy Corporation pays a 3.27% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 64 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| LNT | XBI | |
|---|---|---|
Market Cap | $16.99B | $10.11B |
Volume | 2,488,387 | 12,903,266 |
Sector | Utilities | Broad Market / Factor |
52-Week High | $78.03 | $169.55 |
52-Week Low | $63.21 | $104.99 |
Typical Hold Time | 64 Days | 38 Days |
Enterprise Value | $29.08B | — |
Dividend Yield | 3.27% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $65.50, up 0.44% today, with a bullish technical signal and support near $65. The company reported Q2 2026 EPS of $0.65, beating expectations, and maintains a strong net income margin of 18.45%. Recent news highlights a $1.4B partnership and institutional buying, while a $13.4B capital expenditure plan supports long-term growth.
Outlook is positive with a consensus price target of $77, implying 17.6% upside, driven by steady utility demand and data center growth. Risks include rising debt levels and cost pressures. Analysts are bullish with 52% buy ratings, but investors should monitor execution of the capex plan and interest rate impacts.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
